Home
Stonepine Capital Management reported a 7.9% stake in CNS Pharmaceuticals CNSP · 48,827 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 7.9%
- Last report
- 5.6% · filed 25/11/04
- Shares held
- 48,827 sh
- Class
- Common Stock
- Event date
- 25/12/31
- Filed
- 26/02/13
7.9% stake · +2.3pp from the last report
- Stake
- 7.9%
- Last report
- 5.6%
- Since last report
- +2.3pp
CNS Pharmaceuticals trades, last 26 weeks
What else happened in CNS Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Stonepine Capital Management's other 5% stake reports
- Stonepine Capital Management
5% stakeFemasys
5% stakeFemasys
FEMY
7.2% stake
625,000 sh
7.2% stake
Filed 08/31
- Stonepine Capital Management
5% stakeEdesa Biotech
5% stakeEdesa Biotech
EDSA
6.9% stake
953,739 sh
6.9% stake
Filed 08/26
- Stonepine Capital Management
5% stakeCalciMedica
5% stakeCalciMedica
CALC
6% stake
2,149,522 sh
6% stake
Filed 08/25
- Stonepine Capital Management
5% stakeAeon Biopharma
5% stakeAeon Biopharma
AEON
9.9% stake
6,892,682 sh
9.9% stake
Filed 07/21
- Stonepine Capital Management
5% stakePasithea Therapeutics
5% stakePasithea Therapeutics
KTTA
5.8% stake
1,952,550 sh
5.8% stake
Filed 06/23